Breast Cancer Clinical Trials

Showing 801-820 of 4,817 trials

Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer

NCT01230346

This pilot clinical trial studies a culturally-informed counseling intervention in Latinas at high risk for hereditary breast or ovarian cancer. A culturally-informed counseling intervention may be an effective method to help people learn more about their cancer risk.

No Evidence of DiseaseBRCA1 SyndromeBRCA2 Syndrome+2 more

City of Hope Medical Center493 participantsStarted Sep 2010

Duarte, California, United States • Los Angeles, California, United States • Sylmar, California, United States

RECRUITINGPhase 3

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

NCT06144164

The purpose of this study to test whether a comprehensive program may help the lymph fluid to drain out of the arm and prevent lymphedema in participants with breast cancer.

LymphedemaLymphedema ArmLymphedema of Upper Arm+3 more

Memorial Sloan Kettering Cancer Center285 participantsStarted Nov 2023

Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States • Montvale, New Jersey, United States +4 more locations

Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

Related Searches

Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants

Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)

Multi-center MRD Registry for Inflammatory Breast Cancer

Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast

ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer

Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer

A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors

A Phase II Study of Neoadjuvant Sacituzumab Govitecan and Pembrolizumab Therapy for Immunochemotherapy-resistant Early-stage Triple-negative Breast Cancer (TNBC)

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial

Abbreviated Breast MRI (AB-MRI) With Golden-angle Radial Compressed-sensing and Parallel Imaging (GRASP)

Multiparametric MRI for Assessing Breast Cancer Response to Anti-HER2 Therapy

CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA

A Study of XMT-1660 in Participants With Solid Tumors

Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery

Supporting Women With Breast Cancer to Prepare for Treatment (The Prepare Study)

Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer

Evaluating the Association Between Changes in the Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer